Enterovirus Vaccine Market

Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccines
Enterovirus Vaccine Market contains market size and forecasts of Enterovirus Vaccine in global, including the following market information:
Global Enterovirus Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Enterovirus Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Enterovirus Vaccine companies in 2021 (%)
The global Enterovirus Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Coxasckievirus A Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Enterovirus Vaccine include Sinovac Biotech, Medigen Vaccine Biologics, Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology and Beijing Minhai Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Enterovirus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enterovirus Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Enterovirus Vaccine Market Segment Percentages, by Type, 2021 (%)
Coxasckievirus A
Coxasckievirus B
Human Enterovirus 71
Others
Global Enterovirus Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Enterovirus Vaccine Market Segment Percentages, by Application, 2021 (%)
Hospital
Research Institute
Others
Global Enterovirus Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Enterovirus Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enterovirus Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Enterovirus Vaccine revenues share in global market, 2021 (%)
Key companies Enterovirus Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Enterovirus Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sinovac Biotech
Medigen Vaccine Biologics
Shenzhen Neptunus
Sinopharm
Adimmune
Intravacc
Shanghai Zerun Biotechnology
Beijing Minhai Biotechnology